This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Singhi, P. Articles by Khandelwal, N. Search for Related Content PubMed PubMed Citation Articles by Singhi, P. Articles by Khandelwal, N. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Brain Diseases Steroids Hazardous Substances DB PREDNISOLONE Social Bookmarking                         What's this?

Corticosteroids Versus Albendazole for Treatment of Single Small Enhancing Computed Tomographic Lesions in Children With Neurocysticercosis

Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Vivek Jain, MD

Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Narendra Khandelwal, MD

Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Single small enhancing computed tomographic (CT) lesions representing cysticercus granuloma are a common cause of focal seizures in children. Controversy exists regarding the efficacy of various modalities of treatment. We conducted a randomized prospective trial to evaluate the efficacy of corticosteroids, albendazole, and corticosteroids with albendazole in children with focal seizures and single small enhancing CT lesions. The study population consisted of 133 children with focal seizures of recent onset (< 3 months) and single small enhancing CT lesions who presented to the Neurocysticercosis Clinic of Pediatric Neurology Services at the Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, an urban teaching and tertiary care hospital in Chandigarh, North India. All children were randomly assigned to receive corticosteroids (group S), albendazole (group A), or both corticosteroids and albendazole (group SA) for 28 days. CT was done at 3 and 6 months after enrollment in the study. Of the 133 patients enrolled, 23 were lost to follow-up. Of the remaining 110 patients, 38 patients were in group S, 37 in group A, and 35 in group SA. All children were followed up for at least 18 months. Disappearance of the lesion on CT scan was noted in 52.6% of patients in group S, 59.5% in group A, and 62.9% in Group SA (P > .1) at the 3-month follow-up. After the 6-month follow-up, disappearance of the lesion was noted in 76.3% in group S, 75.7% in group A, and 74.2% in group SA (P > .1). Twenty-three patients had seizure recurrence while on antiepilepsy drugs: 36.8% of patients in group S, 13.5% in group A, and 11.4% in group SA (P < .05). Seizure recurrence after antiepilepsy drug withdrawal was seen in seven children (three in group S and two each in groups A and SA). In conclusion, there was no significant difference in resolution of CT lesions in the three therapy groups at 3 and 6 months of follow-up. Children in the corticosteroid group had significantly more seizure recurrences while on antiepilepsy drugs. (J Child Neurol 2004;19:323-327).

Journal of Child Neurology, Vol. 19, No. 5, 323-327 (2004)
DOI: 10.1177/088307380401900503


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A Carpio, E A Kelvin, E Bagiella, D Leslie, P Leon, H Andrews, W A Hauser, and the Ecuadorian Neurocysticercosis Group Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1050 - 1055. [Abstract] [Full Text] [PDF]

				M. Mazumdar, P. Pandharipande, and A. Poduri Does Albendazole Affect Seizure Remission and Computed Tomography Response in Children With Neurocysticercosis? A Systematic Review and Meta-analysis J Child Neurol, February 1, 2007; 22(2): 135 - 142. [Abstract] [PDF]

				A. I. Bhigjee and S. Rosemberg Optimizing therapy of seizures in patients with HIV and cysticercosis Neurology, December 26, 2006; 67(12_suppl_4): S19 - S22. [Abstract] [Full Text]

				T. E. Nash, G. Singh, A. C. White, V. Rajshekhar, J. A. Loeb, J. V. Proano, O. M. Takayanagui, A. E. Gonzalez, J. A. Butman, C. DeGiorgio, et al. Treatment of neurocysticercosis: current status and future research needs. Neurology, October 10, 2006; 67(7): 1120 - 1127. [Abstract] [Full Text] [PDF]

				Picture of the Month--Diagnosis Arch Pediatr Adolesc Med, October 1, 2006; 160(10): 1082 - 1083. [Full Text] [PDF]

				O. H. Del Brutto, K. L. Roos, C. S. Coffey, and H. H. Garcia Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel Ann Intern Med, July 4, 2006; 145(1): 43 - 51. [Abstract] [Full Text] [PDF]

				P. Singhi and S. Singhi Topical Review: Neurocysticercosis in Children J Child Neurol, July 1, 2004; 19(7): 482 - 492. [Abstract] [PDF]